• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number 10604
Device Problem Material Integrity Problem (2978)
Patient Problem No Patient Involvement (2645)
Event Date 10/16/2020
Event Type  malfunction  
Event Description
It was reported that the device was defective.The patient came in with st-elevation myocardial infarction.The target lesion was located in a coronary vessel.A 2.25x24mm synergy drug-eluting stent was selected for use.However, upon removing the device, it was noticed that there was a bubble or a metal ring formation on the stent hypotube.The device did not enter the patient's body.The procedure was completed with a different device.No patient complications were reported.
 
Manufacturer Narrative
Device evaluation by mfr.: synergy ii us mr 2.25 x 24 mm stent delivery system was returned for analysis.A visual examination of the stent found no issues.There was no sign of damage, stretching or lifting of the stent struts.The stent showed no signs of movement and was set between the proximal and distal markerbands.The crimped stent outer diameter was measured and the result was within maximum crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the tip showed no signs of damage.A visual and tactile examination of the hypotube found multiple kinks along several locations of the hypotube shaft.This type of damage is consistent with excessive force that could have been applied to the delivery system.A visual and tactile examination of the outer and mid-shaft section and visual examination of the inner lumen found no issues with the extrusion shaft.No other issues were noted with the shaft and no anomalies like a bubble was observed.The only "bubble" present is the mid-shaft bond which is part of the device.No other issues were identified during the product analysis.
 
Event Description
It was reported that the device was defective.The patient came in with st-elevation myocardial infarction.The target lesion was located in a coronary artery.A 2.25 x 24 synergy drug-eluting stent was selected for use; however, when removing the stent from the delivery system, it was noticed that there was a bubble or a metal ring formation on the stent hypotube.The device did not enter the patient's body.The procedure was completed with a different device.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10791300
MDR Text Key214755780
Report Number2134265-2020-15185
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840206
UDI-Public08714729840206
Combination Product (y/n)N
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/02/2022
Device Model Number10604
Device Catalogue Number10604
Device Lot Number0025210590
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/29/2020
Initial Date Manufacturer Received 10/16/2020
Initial Date FDA Received11/05/2020
Supplement Dates Manufacturer Received11/25/2020
Supplement Dates FDA Received12/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age55 YR
-
-